Lv1
100 积分 2024-07-23 加入
Acute Kidney Injury in Patients with Cirrhosis
2个月前
已完结
Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis
3个月前
已完结
贝伐珠单抗致蛋白尿的潜在危险因素及保护因素分析
3个月前
已完结
Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities
3个月前
已完结
肺癌患者接受VEGF拮抗剂治疗出现肾损伤的影响因素研究
3个月前
已完结
Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis
4个月前
已完结
Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence
4个月前
已完结
Mechanisms of anti-VEGF therapy-induced kidney injury: current insights and future perspectives in combination with immune checkpoint inhibitors
4个月前
已完结
Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study
4个月前
已完结
Efficacy and Safety of Phosphate-Lowering Agents for Adult Patients with CKD Requiring Dialysis: A Network Meta-Analysis
4个月前
已完结
皖公网安备34019202002308
